British Journal of Haematology · 1992 · 76 citations · 23 references
Life SciencesGeneticsMolecular GeneticsCancer GeneticsCytogeneticsHematologic OncologyCancer CytogeneticsClinical CytogeneticsHematopoietic NeoplasmsMalignant NeoplasmsMolecular CytogeneticsMultiple MyelomaCytogenetic AberrationsMultiple Myeloma Of BoneMyeloma PathogenesisP53 AbnormalityP53 MutationPoint Mutation AnalysisTp53 MutationsTumor Suppressor P53
We looked for mutations of exons 5-8 of the P53 gene in bone marrow cell from 37 cases of multiple myeloma, using polymerase chain reaction-single strand conformation polymorphism (PCR-SSCP) analysis and DNA sequencing. 25 patients also had cytogenetic analysis. A point mutation, leading to an amino acid change in the P53 protein was found in only one case, involving exon 5. These findings suggest that P53 mutations are very rare in multiple myeloma, and that this disease may be categorized among the few neoplasms where P53 abnormalities have very limited role, if any.
23
Mutations in the p53 gene occur in diverse human tumour types
Janice Nigro, Suzanne J. Baker, Antonette C. Preisinger et al. · Nature · 1989 · 2.8K citations · Full text
The p53 proto-oncogene can act as a suppressor of transformation
Cathy A. Finlay, Philip W. Hinds, Arnold J. Levine · Cell · 1989 · 2K citations
p53: A Frequent Target for Genetic Abnormalities in Lung Cancer
Takashi Takahashi, Marion M. Nau, Itsuo Chiba et al. · Science · 1989 · 1.2K citations